A decreased BrdU incorporation in PRRX1 siRNA-treated control and IPF lung fibroblasts also supported a potential G1/S arrest in these cells compared to control siRNA-treated lung fibroblasts at 72 hr (Figure 4—figure supplement 1). This evidence concerns the gene PRRX1 and idiopathic pulmonary fibrosis.